Company
United StatesStemline Therapeutics, Inc., New York, NY – FDA Inspections
Inspection records and compliance data for Stemline Therapeutics, Inc. in New York, New York. 2 FDA inspections on record, last inspected August 31, 2023.
Company Profile
This profile covers Stemline Therapeutics, Inc. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected May 1, 2018. Last inspected August 31, 2023.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 31, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1218674 |
| May 1, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1054574 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Stemline Therapeutics, Inc.
FEI Number
3012004287
Address
750 Lexington Ave Frnt 4, New York, New York 10022, United States
Country
United States
ID: 21250514-bb46-4729-9657-03252dd4a4ac